Collegium Pharmaceutical Inc’s recently made public that its Officer Tupper Colleen acquired Company’s shares for reported $0.19 million on Mar 21 ’25. In the deal valued at $30.03 per share,6,396 shares were bought.
Then, Dreyer Scott bought 18,881 shares, generating $566,984 in total proceeds.
Before that, Tupper Colleen bought 1,206 shares. Collegium Pharmaceutical Inc shares valued at $36,181 were divested by the Officer at a price of $30.00 per share.
Needham upgraded its Collegium Pharmaceutical Inc [COLL] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who increased its forecast for the stock in late July from “a Neutral” to “a Buy”. Jefferies also remained covering COLL and has increased its forecast on June 07, 2024 with a “Buy” recommendation from previously “Hold” rating. Piper Sandler revised its rating on May 10, 2024. It rated COLL as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of COLL
On Friday, Collegium Pharmaceutical Inc [NASDAQ:COLL] saw its stock jump 0.40% to $30.05. Over the last five days, the stock has gained 2.00%. Collegium Pharmaceutical Inc shares have risen nearly 4.89% since the year began. Nevertheless, the stocks have fallen -20.84% over the past one year. While a 52-week high of $42.29 was reached on 01/10/25, a 52-week low of $27.27 was recorded on 03/05/25. SMA at 50 days reached $30.76, while 200 days put it at $33.15.
Levels Of Support And Resistance For COLL Stock
The 24-hour chart illustrates a support level at 29.36, which if violated will result in even more drops to 28.66. On the upside, there is a resistance level at 30.64. A further resistance level may holdings at 31.22. The Relative Strength Index (RSI) on the 14-day chart is 52.82, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.49, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 14.75%. Stochastics %K at 81.03% indicates the stock is a selling.
How much short interest is there in Collegium Pharmaceutical Inc?
A steep rise in short interest was recorded in Collegium Pharmaceutical Inc stocks on 2025-02-28, dropping by -0.27 million shares to a total of 5.41 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 5.68 million shares. There was a decline of -4.96%, which implies that there is a negative sentiment for the stock.
